Baclofen for the Treatment of Cocaine Dependence - 1
- Registration Number
- NCT00082485
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Brief Summary
The purpose of this study is to assess the efficacy and safety of baclofen for the treatment of cocaine dependence.
- Detailed Description
Double-blind, placebo-controlled, parallel design trial of baclofen for the treatment of cocaine dependence
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
- Subject must have DSM-IV diagnosis of cocaine dependence.
- Subject must be seeking treatment for cocaine dependence.
- Be be able to verbalize understanding of consent form, provide written consent and verbalize willingness to complete study procedures.
Exclusion Criteria
- Please contact site for more information.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 Baclofen - 2 Placebo -
- Primary Outcome Measures
Name Time Method Effects of medication on cocaine craving
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (8)
San Francisco General Hosptial
🇺🇸San Francisco, California, United States
Denver VA Medical Center
🇺🇸Denver, Colorado, United States
South TX VA Health Care System
🇺🇸San Antonio, Texas, United States
Salt Lake City VA Medical Center
🇺🇸Salt Lake City, Utah, United States
Institute of Resch & Educ Inova Fairfax Hospital
🇺🇸Falls Church, Virginia, United States
Torrance Site
🇺🇸Torrance, California, United States
VA Maryland Healthcare System
🇺🇸Baltimore, Maryland, United States
U of Penn School of Medicine
🇺🇸Philadelphia, Pennsylvania, United States